Financial insights of ASRT

MyFinsight

For the year ending 2025-12-31, ASRT made $118,713K in revenue. -$30,375K in net income. Net profit margin of -25.59%.

Income Statement	2025-12-31
Total revenues	118,713
Cost of sales	35,383
Research and development expenses	1,690
Selling, general and administrative expenses	69,000
Change in fair value of contingent consideration	-276
Amortization of intangible assets	29,863
Impairment of intangible assets	1,700
Restructuring charges	2,889
Total costs and expenses	140,249
Loss from operations	-21,536
Loss on assertio therapeutics divestiture	-8,174
Interest expense	3,075
Interest income	2,665
Other gain, net	180
Total other (expense) income	-8,404
Net loss before income taxes	-29,940
Income tax expense	435
Net loss and comprehensive loss	-30,375

Basic EPS	-4.74
Diluted EPS	-4.74
Basic Average Shares	6,403,000
Diluted Average Shares	6,403,000